GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinotherapeutics Inc (SHSE:688247) » Definitions » Notes Receivable

Sinotherapeutics (SHSE:688247) Notes Receivable : ¥0.0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sinotherapeutics Notes Receivable?

Sinotherapeutics's Notes Receivable for the quarter that ended in Mar. 2024 was ¥0.0 Mil.


Sinotherapeutics Notes Receivable Historical Data

The historical data trend for Sinotherapeutics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinotherapeutics Notes Receivable Chart

Sinotherapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
Get a 7-Day Free Trial - - - - -

Sinotherapeutics Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sinotherapeutics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Sinotherapeutics Notes Receivable Related Terms

Thank you for viewing the detailed overview of Sinotherapeutics's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinotherapeutics (SHSE:688247) Business Description

Traded in Other Exchanges
N/A
Address
No. 515 Huanke Road, Room 205 and 207, Pilot Free Trade Zone, Shanghai, CHN, 201203
Sinotherapeutics Inc is engaged in the research and development, production and sales of generic drugs and CRO services.

Sinotherapeutics (SHSE:688247) Headlines

No Headlines